Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bassi

Showing results (361-370 of 422) with videos related to

Pageof 43
Sort By:
Surgery|May 27, 2014
Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)Werner Hartwig, Charles M Vollmer, Abe Fingerhut, et al.
Surgery|March 26, 2014
When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic SurgeryHoracio J Asbun, Kevin Conlon, Laureano Fernandez-Cruz, et al.
The American Journal of Gastroenterology|April 22, 2010
Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory processJ-Matthias Löhr, Ralf Faissner, Dirk Koczan, et al.
Cancer Letters|November 23, 2024
Local ablation disrupts immune evasion in pancreatic cancerChiara Musiu, Annalisa Adamo, Simone Caligola, et al.
JAMA Surgery|October 5, 2018
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic CancerStijn van Roessel, Gyulnara G Kasumova, Joanne Verheij, et al.
Annals of Surgery|March 17, 2015
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus MeetingVolkan Adsay, Mari Mino-Kenudson, Toru Furukawa, et al.
Annals of Surgery|September 23, 2017
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External ValidationLaura Maggino, Giuseppe Malleo, Claudio Bassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 studyJuan W Valle, Daniel Palmer, Richard Jackson, et al.
Surgery|May 27, 2014
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)Maximilian Bockhorn, Faik G Uzunoglu, Mustapha Adham, et al.
JAMA|September 9, 2010
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trialJohn P Neoptolemos, Deborah D Stocken, Claudio Bassi, et al.
Pageof 43

Showing results (361-370 of 422) with videos related to

Sort By:
Pageof 43
Surgery|May 27, 2014
Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)Werner Hartwig, Charles M Vollmer, Abe Fingerhut, et al.
Surgery|March 26, 2014
When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic SurgeryHoracio J Asbun, Kevin Conlon, Laureano Fernandez-Cruz, et al.
The American Journal of Gastroenterology|April 22, 2010
Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory processJ-Matthias Löhr, Ralf Faissner, Dirk Koczan, et al.
Cancer Letters|November 23, 2024
Local ablation disrupts immune evasion in pancreatic cancerChiara Musiu, Annalisa Adamo, Simone Caligola, et al.
JAMA Surgery|October 5, 2018
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic CancerStijn van Roessel, Gyulnara G Kasumova, Joanne Verheij, et al.
Annals of Surgery|March 17, 2015
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus MeetingVolkan Adsay, Mari Mino-Kenudson, Toru Furukawa, et al.
Annals of Surgery|September 23, 2017
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External ValidationLaura Maggino, Giuseppe Malleo, Claudio Bassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 studyJuan W Valle, Daniel Palmer, Richard Jackson, et al.
Surgery|May 27, 2014
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)Maximilian Bockhorn, Faik G Uzunoglu, Mustapha Adham, et al.
JAMA|September 9, 2010
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trialJohn P Neoptolemos, Deborah D Stocken, Claudio Bassi, et al.
Pageof 43